These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 15342417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L, Barth RF, Tjarks W, Soloway AH, Anisuzzaman AK.
    Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
    [Abstract] [Full Text] [Related]

  • 3. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA.
    Cancer Res; 2002 Jun 01; 62(11):3159-66. PubMed ID: 12036929
    [Abstract] [Full Text] [Related]

  • 4. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Cancer Res; 1997 Mar 15; 57(6):1129-36. PubMed ID: 9067283
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
    Yang W, Barth RF, Wu G, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Binns PJ, Riley K, Patel H, Coderre JA, Ciesielski MJ, Fenstermaker RA.
    Appl Radiat Isot; 2004 Nov 15; 61(5):981-5. PubMed ID: 15308179
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors.
    Takagaki M, Ono K, Oda Y, Kikuchi H, Nemoto H, Iwamoto S, Cai J, Yamamoto Y.
    Cancer Res; 1996 May 01; 56(9):2017-20. PubMed ID: 8616843
    [Abstract] [Full Text] [Related]

  • 12. Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapy.
    Sjuvarsson E, Damaraju VL, Mowles D, Sawyer MB, Tiwari R, Agarwal HK, Khalil A, Hasabelnaby S, Goudah A, Nakkula RJ, Barth RF, Cass CE, Eriksson S, Tjarks W.
    J Pharmacol Exp Ther; 2013 Nov 01; 347(2):388-97. PubMed ID: 24006340
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors.
    Zhuo JC, Cai J, Soloway AH, Barth RF, Adams DM, Ji W, Tjarks W.
    J Med Chem; 1999 Apr 08; 42(7):1282-92. PubMed ID: 10197971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Boron-containing polyamines as DNA targeting agents for neutron capture therapy of brain tumors: synthesis and biological evaluation.
    Cai J, Soloway AH, Barth RF, Adams DM, Hariharan JR, Wyzlic IM, Radcliffe K.
    J Med Chem; 1997 Nov 21; 40(24):3887-96. PubMed ID: 9397169
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors.
    Barth RF, Yang W, Nakkula RJ, Byun Y, Tjarks W, Wu LC, Binns PJ, Riley KJ.
    Appl Radiat Isot; 2015 Dec 21; 106():251-5. PubMed ID: 26282567
    [Abstract] [Full Text] [Related]

  • 19. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
    Tjarks W, Barth RF, Rotaru JH, Adams DM, Yang W, Kultyshev RG, Forrester J, Barnum BA, Soloway AH, Shore SG.
    Anticancer Res; 2001 Dec 21; 21(2A):841-6. PubMed ID: 11396173
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer.
    Tjarks W, Wang J, Chandra S, Ji W, Zhuo J, Lunato AJ, Boyer C, Li Q, Usova EV, Eriksson S, Morrison GH, Cosquer GY.
    Nucleosides Nucleotides Nucleic Acids; 2001 Dec 21; 20(4-7):695-8. PubMed ID: 11563094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.